Skip to main content

LIVE FROM MARKETPLACE: Kicking the habit with Nicorette


PITTSBURGH GlaxoSmithKline plans to launch the first recently FDA-approved innovation into the smoking cessation category in seven years.

With a planned launch of Aug. 31, the product differentiators include a handy, convenience dispenser for discreet on-the-go use and a smaller lozenge that dissolves three-times faster than the classic lozenge and delivers the entire dose of nicotine within some 10 minutes.

This ad will auto-close in 10 seconds